Ekaterina Manuilova
Overview
Explore the profile of Ekaterina Manuilova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schinke H, Fornvik Jonsson M, Gummesson M, Nilsson R, Gaupp S, Manuilova E, et al.
Clin Chem Lab Med
. 2025 Mar;
PMID: 40068924
Objectives: The Apollo study was designed to support the clinical performance verification of the adjusted cutoffs of the Elecsys β-Amyloid(1-42) (Aβ) cerebrospinal fluid (CSF) II, β-Amyloid(1-40) (Aβ) CSF, Phospho-Tau (181P)...
2.
Blennow K, Stomrud E, Zetterberg H, Borlinghaus N, Corradini V, Manuilova E, et al.
Clin Chem Lab Med
. 2022 Oct;
61(2):234-244.
PMID: 36282960
Objectives: Timely diagnosis of Alzheimer's disease (AD) is critical for appropriate treatment/patient management. Cerebrospinal fluid (CSF) biomarker analysis is often used to aid diagnosis. We assessed analytical performance of second-generation...
3.
Rabe C, Bittner T, Jethwa A, Suridjan I, Manuilova E, Friesenhahn M, et al.
Alzheimers Dement
. 2022 Sep;
19(4):1393-1402.
PMID: 36150024
Introduction: Further evidence is needed to support the use of plasma amyloid β (Aβ) biomarkers as Alzheimer's disease prescreening tools. This study evaluated the clinical performance and robustness of plasma...
4.
Klafki H, Vogelgsang J, Manuilova E, Bauer C, Jethwa A, Esselmann H, et al.
Alzheimers Res Ther
. 2022 Sep;
14(1):127.
PMID: 36071505
Background: Measurements of the amyloid-β (Aβ) 42/40 ratio in blood plasma may support the early diagnosis of Alzheimer's disease and aid in the selection of suitable participants in clinical trials....
5.
Palmqvist S, Stomrud E, Cullen N, Janelidze S, Manuilova E, Jethwa A, et al.
Alzheimers Dement
. 2022 Aug;
19(4):1204-1215.
PMID: 35950735
Introduction: There is a great need for fully automated plasma assays that can measure amyloid beta (Aβ) pathology and predict future Alzheimer's disease (AD) dementia. Methods: Two cohorts (n = ...
6.
Hansson O, Rutz S, Zetterberg H, Bauer E, Hahl T, Manuilova E, et al.
Alzheimers Dement (Amst)
. 2020 Dec;
12(1):e12137.
PMID: 33354617
Introduction: We aimed to establish a standardized, routine-use pre-analytical protocol for measuring Alzheimer's disease (AD) biomarkers in cerebrospinal fluid (CSF). Methods: The effect of pre-analytical factors (sample collection/handling/storage/transportation) on biomarker...
7.
Boulo S, Kuhlmann J, Andreasson U, Brix B, Venkataraman I, Herbst V, et al.
Alzheimers Dement
. 2020 Aug;
16(11):1493-1503.
PMID: 32755010
Introduction: Reference materials based on human cerebrospinal fluid were certified for the mass concentration of amyloid beta (Aβ)1-42 (Aβ ). They are intended to be used to calibrate diagnostic assays...
8.
Doecke J, Ward L, Burnham S, Villemagne V, Li Q, Collins S, et al.
Alzheimers Res Ther
. 2020 Apr;
12(1):36.
PMID: 32234072
Background: β-amyloid (Aβ) positron emission tomography (PET) imaging is currently the only Food and Drug Administration-approved method to support clinical diagnosis of Alzheimer's disease (AD). However, numerous research studies support...
9.
Lifke V, Kollmorgen G, Manuilova E, Oelschlaegel T, Hillringhaus L, Widmann M, et al.
Clin Biochem
. 2019 May;
72:30-38.
PMID: 31129184
Background: Total tau (tTau) and phosphorylated 181P tau (pTau) are supportive diagnostic cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease. Manual CSF tau assays are limited by lot-to-lot and between-laboratory variability...
10.
Shaw L, Hansson O, Manuilova E, Masters C, Doecke J, Li Q, et al.
Clin Biochem
. 2019 May;
72:7-14.
PMID: 31129181
Background: Alzheimer's disease (AD) biomarkers, such as cerebrospinal fluid (CSF) amyloid-β (1-42; Aβ42), can provide high diagnostic accuracy. Several immunoassays are available for Aβ42 quantitation, but standardisation across assays remains...